ACT Stock Analysis: Buy, Sell, or Hold?

ACT - Enact Holdings, Inc. Common Stock

INSURANCE AGENTS, BROKERS & SERVICE
$39.77
-0.37 (-0.92%) ▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 03, 2026 2d

Get Alerted When ACT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: ACT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$48.28
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$29.98
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.5x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: ACT is currently trading at $39.77, which is considered fair relative to its 30-day fair value range of $38.87 to $40.33. The stock's valuation (Forward PE: 8.6) is in line with its historical norms (8.5). At these levels, the market is pricing in 0.6% annual earnings growth.

Technical Outlook: Technically, ACT is in a uptrend. The price is approaching resistance at $40.22. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: ACT has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $38.87 - $40.33
Company Quality Score 63/100 (BUY)
Volume Confirmation HIGH
Confidence Score 85.4%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($42.20)
  • BULLISH: Expecting earnings turnaround to 0.6% growth with 0.6% revenue growth

Fair Price Analysis

30-Day Fair Range $38.87 - $40.33
Current vs Fair Value FAIR
Expected Move (7 Days) ±$1.21 (3.0%)

Support & Resistance Levels

Support Level $38.25
Resistance Level $40.22
Current Trend Uptrend

Fundamental Context

Forward P/E (Next Year Est.) 8.62
Wall Street Target $42.20 (+5.1%)
Revenue Growth (YoY) 0.6%
Earnings Growth (YoY) -4.3%
Profit Margin 53.9%
Valuation Premium vs History +0.6% premium
PE vs Historical 8.6 vs 8.5 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +0.6% (market-implied from PE analysis)
1-Year Target $40.38 (+1%)
2-Year Target $40.62 (+1%)
3-Year Target $40.87 (+2%)
3-Yr Target (if PE normalizes) (PE: 9→9) PE COMPRESSION $40.30 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 4.1%) $117.00 (+192%)
Base: (SPY PE: 8.6, Growth: 4.1%) $45.22 (+13%)
Bear: (PE: 7.3, Growth: 4.1%) $38.44 (-4%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (9x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 9.02 | Current EPS (TTM): $4.36
Bull Case $46.19 (+16%)
Analyst growth 6.8%, PE expands to 9.9
Base Case $41.99 (+6%)
Market implied 6.8%, PE stable at 9.0
Bear Case $26.73 (-33%)
Severe decline -20.0%, PE contracts to 7.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Last updated: January 30, 2026 7:44 PM ET
Data refreshes hourly during market hours. Next update: 8:44 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Insurance - Specialty Stocks

Top-rated stocks in Insurance - Specialty by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RYAN
Ryan Specialty Group Hol…
BUY
13 analysts
$64 45 HOLD
AXS
AXIS Capital Holdings Ltd
BUY
9 analysts
$121 59 HOLD
ESNT
Essent Group Ltd
BUY
8 analysts
$69 65 BUY
NMIH
NMI Holdings Inc
STRONG BUY
7 analysts
$45 54 HOLD
RDN
Radian Group Inc
BUY
6 analysts
$39 55 HOLD

Advanced ACT Option Strategies

Professional options setups generated by AI based on today's ACT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for ACT

ACT Technical Chart ACT Price Prediction ACT Earnings Date ACT Investment Advisor ACT Fair Price Analyzer ACT Options Advisor ACT Options Chain ACT Options Analysis ACT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals